Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of New Brunswick

$27,000.00

Bioactive natural products from fungal endophytes

EF 2009-10

Résumé
The threat to human health as a result of the growing emergence of bacterial resistance to antibiotic agents is both real and significant. It is alarming to realise that microbial strains resistant to all of the major classes of antibiotics currently in clinical use have been identified, and pan-resistant pathogens are beginning to emerge. Despite the rapid increase in bacterial resistance, only two new classes of antibiotics have reached the clinics in the last forty years. There is, therefore, an obvious and urgent need to develop new antibiotic agents with novel modes of action and new pharmacophores to combat infectious disease. Natural products chemistry often provides access to unprecedented lead structures with desirable bioactivities and potencies and has uncovered a vast number of biologically active organic compounds with genuine potential to become or inspire new therapeutics, health products, agrochemicals and antifoulants. We are only beginning to acknowledge the full potential of the molecules present in the world's biodiversity and can expect the continued discovery of many useful natural products in the future. My research program focuses on the isolation and synthesis of biologically active natural products that exhibit activity against drug resistant strains of pathogenic microbes, and consequently have significant potential as lead compounds for the development of new therapeutics for infectious disease. We will initially focus on natural products produced by endophytic fungi of terrestrial, marine and freshwater plants. A library of 250 fungal endophyte cultures is currently under investigation, and additional endophytic strains will be isolated, cultured and extracted to augment our collection. Extracts that exhibit promising bioactivity will be subjected to bioassay guided fractionation using a suite of pathogenic microbes to isolate and identify the active components in an effort to discover lead compounds for the development of new therapeutics to fight infectious disease.
Programme
Discovery Grants Program - Individual
Emplacement
New Brunswick, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
350764-2009
Name nom
Gray, Christopher
Department département
Chemistry
Organization id
75
Institution établissement
University of New Brunswick
Province en
New Brunswick
Province fr
Nouveau-Brunswick
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
27000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3701
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Natural products
Research subject fr
Produits naturels
Partie
1
Nb partie
5
Application title
Bioactive natural products from fungal endophytes
Keyword
NA
Application summary
The threat to human health as a result of the growing emergence of bacterial resistance to antibiotic agents is both real and significant. It is alarming to realise that microbial strains resistant to all of the major classes of antibiotics currently in clinical use have been identified, and pan-resistant pathogens are beginning to emerge. Despite the rapid increase in bacterial resistance, only two new classes of antibiotics have reached the clinics in the last forty years. There is, therefore, an obvious and urgent need to develop new antibiotic agents with novel modes of action and new pharmacophores to combat infectious disease. Natural products chemistry often provides access to unprecedented lead structures with desirable bioactivities and potencies and has uncovered a vast number of biologically active organic compounds with genuine potential to become or inspire new therapeutics, health products, agrochemicals and antifoulants. We are only beginning to acknowledge the full potential of the molecules present in the world's biodiversity and can expect the continued discovery of many useful natural products in the future. My research program focuses on the isolation and synthesis of biologically active natural products that exhibit activity against drug resistant strains of pathogenic microbes, and consequently have significant potential as lead compounds for the development of new therapeutics for infectious disease. We will initially focus on natural products produced by endophytic fungi of terrestrial, marine and freshwater plants. A library of 250 fungal endophyte cultures is currently under investigation, and additional endophytic strains will be isolated, cultured and extracted to augment our collection. Extracts that exhibit promising bioactivity will be subjected to bioassay guided fractionation using a suite of pathogenic microbes to isolate and identify the active components in an effort to discover lead compounds for the development of new therapeutics to fight infectious disease.